RCC10RGBHomo sapiens (Human)Cancer cell line

Also known as: Hpt.10, RGB, 10RGB, RCC10 RGB, RCC-10RGB

🤖 AI SummaryBased on 9 publications

Quick Overview

RCC10RGB is a human renal cell carcinoma cell line used in cancer research.

Detailed Summary

RCC10RGB is a human renal cell carcinoma (RCC) cell line that has been utilized in various studies related to cancer biology and drug sensitivity. It is part of the Cancer Cell Line Encyclopedia (CCLE) and has been analyzed for its genetic and molecular characteristics. Research involving RCC10RGB has focused on understanding the role of thymidine phosphorylase (TP) in the response to chemotherapeutic agents such as 5-fluorouracil (5-FU) and 5'-deoxy-5-fluorouridine (5'-DFUR). Studies have shown that the expression of TP can influence the sensitivity of RCC cell lines to these drugs, with RCC10RGB demonstrating specific patterns of TP expression and response. Additionally, RCC10RGB has been used in investigations into the genomic and transcriptomic profiles of RCC, contributing to the understanding of molecular mechanisms underlying this type of cancer. The cell line is also part of efforts to develop predictive models for anticancer drug sensitivity and has been included in studies examining the relationship between genetic mutations and therapeutic outcomes.

Research Applications

Cancer biology researchDrug sensitivity profilingGenomic and transcriptomic analysisThymidine phosphorylase (TP) expression studiesPredictive modeling of anticancer drug response

Key Characteristics

Expresses thymidine phosphorylase (TP)Sensitivity to 5-fluorouracil (5-FU) and 5'-deoxy-5-fluorouridine (5'-DFUR)Part of the Cancer Cell Line Encyclopedia (CCLE)Used in studies of renal cell carcinoma (RCC) molecular mechanisms
Generated on 6/17/2025

Basic Information

Database IDCVCL_1647
SpeciesHomo sapiens (Human)
Tissue SourceKidney[UBERON:UBERON_0002113]

Donor Information

Age CategoryUnknown
SexMale
Raceasian

Disease Information

DiseaseRenal cell carcinoma
LineageKidney
SubtypeRenal Cell Carcinoma
OncoTree CodeRCC

DepMap Information

Source TypeRIKEN
Source IDACH-000189_source

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11
D13S317
11,12
D16S539
12,13
D18S51
15
D21S11
29,30
D5S818
10,12
D7S820
12,13
D8S1179
12,16
FGA
24,25
TH01
6,9
TPOX
8
vWA
14,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.

Hsieh J.J.-D., Hakimi A.A.

Nat. Commun. 8:15165.1-15165.10(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with interferon-alpha in renal cell carcinoma cell lines.

Nakatani T.

Urol. Int. 73:348-353(2004).

Effects of tumor necrosis factor alpha in renal cell carcinoma.";

Nakatani T.

Oncol. Rep. 10:1947-1955(2003).

Short tandem repeat profiling provides an international reference standard for human cell lines.

Harrison M., Virmani A.K., Ward T.H., Ayres K.L., Debenham P.G.

Proc. Natl. Acad. Sci. U.S.A. 98:8012-8017(2001).

Expression of the SART1 tumor rejection antigen in renal cell carcinoma.

Yoshizumi O., Itoh K.

Urol. Res. 28:178-184(2000).